Show Summary Details
Page of

Antiepileptic Drugs in Patients on Chemotherapy or Immunosuppressive Therapy 

Antiepileptic Drugs in Patients on Chemotherapy or Immunosuppressive Therapy
Chapter:
Antiepileptic Drugs in Patients on Chemotherapy or Immunosuppressive Therapy
Author(s):

Ali A. Asadi-Pooya

and Michael R. Sperling

DOI:
10.1093/med/9780190214968.003.0019
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 19 August 2019

Patients with cancer are at high risk for drug-drug interactions. Antiepileptic drugs (AEDs) are indicated in patients with cancer who present with epilepsy. Chemotherapeutic agents may lose effectiveness when enzyme-inducing AEDs are prescribed. It is advisable to use AEDs that do not interfere with the cytochrome P-450 enzyme complex.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.